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Introduction 
Today an increasing number of patients require cardiac 
surgery. They are often elderly and have severe cardiac 
disease, thus constituting an important risk for perioper- 
ative complications. Atrial tachyarrhythmia, such as 
atrial fibrillation, atrial flutter, or atrial tachycardia, fre- 
quently complicates cardiac surgery and is now rec- 
ognized as a major cause of morbidity. Hypotension, 
hemodynamic nstability, congestive heart failure, and 
thromboembolic complications due to postoperative 
atrial tachyarrhythmias may lengthen the period of hos- 
pitalization and increase costs. 
Here we review risk factors and pathophysiological 
mechanisms of postoperative atrial tachyarrhythmia. 
Prophylactic and therapeutic measures are discussed. 
Incidence and time occurrence of atrial tachyarrhythmias 
The reported incidence of atrial tachyarrhythmias fol- 
lowing cardiac surgery varies from 10 to 40 % in the post- 
operative period [1-19]. This wide range is at least in part 
due to differences inthe protocols of the studies cited. Pa- 
tient populations, type of cardiac surgery, definition, du- 
ration, and hemodynamic effect of atrial tachyarrhyth- 
mia, withdrawal of antiarrhythmic drugs used preopera- 
tively, and duration and type of postoperative rhythm 
monitoring frequently vary, making it difficult o indicate 
precisely the true incidence of this complication. Despite 
increasing expertise in managing patients undergoing 
cardiac surgery, the incidence of these arrhythmias seems 
not to have declined in the past 10-15 years [17, 20]. Atri- 
al tachyarrhythmias can develop immediately or several 
days after surgery. They are most often observed uring 
the second to fourth postoperative day [1-3, 6, 10-12, 15, 
18, 21-28]. Sustained atrial fibrillation and flutter are of- 
ten preceded by atrial ectopic activity, atrial tachycardia, 
or nonsustained atrial fibrillation [13, 25]. 
Etiology and risk factors of atrial tachyarrhythmias 
In patients who have not had cardiac surgery, the mech- 
anisms underlying atrial fibrillation have been studied 
extensively. Several models have been developed. 
Based on mathematical modelling the "multiple wavelet 
hypothesis" has been proposed [29], which suggests that 
excitation of the atrium during fibrillation is the conse- 
quence of multiple, self-sustaining re-entrant wavelets. 
The electrophysiological basis for this model was de- 
scribed as the "leading circle reentry" in a rabbit model 
[30], in which electrical activation becomes fractionated 
as it divides about islets of refractory tissue (circular 
movement around an area of functional block). Further 
support for the re-entrant mechanism resulted from the 
demonstration of local entrainment of the arrhythmia 
during rapid pacing [31]. 
In some patients without structural heart disease the 
surface lectrocardiographic pattern of atrial fibrillation 
is due to a focal, rapidly firing source of activity. These 
sources have been identified and successfully eliminated 
by radiofrequency ablation [32]. 
Much less is known of the pathophysiology of post- 
operative atrial fibrillation. Whether the responsible 
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factors lead either to abnormally high inducibility or to 
abnormally high stability of established atrial fibrilla- 
tion is unclear. A number of cardiac-associated periop- 
erative problems are thought o be responsible: postop- 
eratively raised levels of catecholamines [33] (in some 
cases intensified by withdrawal of beta blockers) or 
pericarditis [34] may be involved. With increasing age, 
atrial dilatation [35, 36], enlarged left ventricular mass 
[35], and calcification of the mitral annulus [36, 37] are 
more common. It is possible that these are responsible 
for atrial conduction delay, and they probably represent 
in many patients acritical prerequisite for atrial re-entry 
and arrhythmia. Thus, the signal-averaged electrocar- 
diogram is a potent predictor of atrial fibrillation after 
cardiac surgery [11]. 
Whereas hypokalemia s known to be related to ven- 
tricular arrhythmia,  correlation to supraventricular ar-
rhythmia in patients after cardiac surgery is controver- 
sial [38, 39], Thus, myocardial potassium concentration 
in the right atrium was similar in patients experiencing 
atrial fibrillation compared to patients with sinus 
rhythm [28]. 
It is clearly desirable to identify risk factors for atrial 
tachyarrhythmias. Several important studies have 
found increasing age [6, 16, 17, 20, 25, 28, 40, 41], heart 
valve surgery [16, 42], a history of atrial fibrillation [16, 
41, 42], and prolonged signal-averaged p-wave duration 
[11, 43] to be predictive of postoperative atrial tachyar- 
rhythmia. Conflicting results have been published for: 
sex [6, 16, 17, 20, 40, 43, 44], left ventricular end-diastol- 
ic pressure [20, 40, 41], aortic cross-clamp time [16, 20, 
25, 28, 40, 43-45], arterial hypertension [17, 20, 43], 
ejection fraction [20, 40, 43, 45], and chronic obstruc- 
tive pulmonary disease [16, 20]. Postoperative with- 
drawal of beta blockers has been identified as a possi- 
ble risk factor for atrial tachyarrhythmia, but no con- 
trolled study has addressed this question. The number 
of bypass grafts [25, 40, 43, 44] and a prior history of 
myocardial infarction [16, 40, 43, 44] are not risk fac- 
tors. 
Consequences of postoperative atrial tachyarrhythmia 
Atrial tachyarrhythmia may be of short duration and is 
often well tolerated [3, 24, 45]. By contrast, it can lead 
to important hemodynamic deterioration with a signifi- 
cant decline in cardiac output leading to congestive 
heart failure [16]. This complication is frequently ob- 
served in patients with pre-existing cardiac ischemia, 
poor left ventricular function, rapid ventricular rate, or 
reduced ventricular compliance. The poorly compliant 
ventricle needs atrial contraction i  order to gain suffi- 
cient preload. A significant increase in cardiac index 
from 2.7 to 3.4 1/min per m 2 as well as a decrease in pul- 
monary arterial diastolic pressure have b en observed 
in patients who converted from postoperative atrial fi- 
brillation to sinus rhythm [46]. A rapid conversion to si- 
nus rhythm is therefore imperative n patients with 
hemodynamic instability. 
Atrial tachyarrhythmia c n lead to systemic throm- 
boembolism and cause transient, or severe and persis- 
tent, neurologic deficit [6, 20, 47-49]. After coronary ar- 
tery bypass in 453 patients, atrial fibrillation alone in- 
creased the probability of stroke or transient ischemic 
attack from 0.78 to 3.9 % during the postoperative p ri- 
od [49]. In 108 patients with carotid bruits, postopera- 
tive atrial fibrillation was an important risk factor for 
stroke or transient ischemic attack [47]. Patients with a 
previous history of cerebrovascular events were at high- 
est risk for this severe complication. 
Patients with atrial tachyarrhythmia stay significant- 
ly longer in the intensive care unit (ICU), are more of- 
ten readmitted to the ICU [16, 19, 20, 50]. and have a 
longer total duration of hospitalization [3, 12, 16, 51], re- 
sulting in additional costs estimated variously at U.S. 
$1600 etc. [16], U.S, $4500 [7], U.S.$ 8000 [19], or 
U. S. $10000 [17]. Whereas other factors often associat- 
ed with postoperative atrial tachyarrhythmia (such as 
age and postoperative complications) contribute to pro- 
longed hospitalization, atrial fibrillation is independent- 
ly associated with an increased length of stay of 4.9 days 
[17]. Postoperative atrial fibrillation is therefore an im- 
portant drain on hospital resources, contributing signifi- 
cantly to the escalating health costs associated with cor- 
onary artery bypass grafting. 
Prevention of postoperative atrial tachyarrhythmias 
It has been suggested that routine pharmacological pro- 
phylaxis of postoperative atrial tachyarrhythmia may 
lead to the administration f unnecessary medication 
to a majority of patients, with a financial burden and 
risk of pharmacologic side effects [3, 50]. However, con- 
sidering the medical and financial consequences of post- 
operative atria1 tachyarrhythmias, it is obvious that an 
effective, nontoxic prophylactic drug regimen, at least 
for patients at risk, would be highly desirable. An over- 
view of trials evaluating the efficiency of drugs in pre- 
venting postoperative atrial tachyarrhythmias is pre- 
sented in Table 1. Summarized are only prospective ran- 
domized trials including at least 50 patients. 
Propafenone has been compared in a double-blinded 
study with atenolol in 207 patients [14]: the incidence of 
atrial tachyarrhythmias was the same in both groups, al- 
though preoperative beta blockers were stopped in the 
propafenone group. 
Beta blockers are the most widely studied agents ap- 
plied for prophylactic purposes: propranolol [1, 3, 15, 
52], acebutolol [22], atenolol [5], metoprolol [2], and na- 
dolol [4] have all been compared to placebo. In all trials, 
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Table 1 Drug efficiency in prophylaxis of postoperative atrial tachyarrhythmia (randomized, prospective studies published from 1976 to 
1997 including at least 50 patients) 
Authors Type of study Number of patients Type of operation Proceeding A and efficiency a Proceeding B
Johnson et al. [23] Open 120 CABG 
Tyras et al. [48] Open 140 CABG 
Csicsko et al. [57] Open 407 CABG 
Hammon et al. [52] Double-blinded 50 CABG 
Matangi et al. [1] Open 164 CABG 
Williams et al. [27] Double-blinded 141 CABG 
Smith et al. [24] Open 100 CABG 
Davison et al. [55] Double-blinded 200 CABG 
Daudon et al. [22] Open 100 CABG 
Janssen et al. [2] Open 1251 CABG 
Rubin et al. [3] Open 123 CABG 
Khuri et al. [4] Double-blinded 148 CABG 
Lamb et al. [5] Open 60 CABG 
Suttorp et al. [44] Double-blinded 300 CABG 
Hohnloser et al. [54] Open 77 CABG 
Fanning et al. [8] Double-blinded 99 CABG 
England et al. [9] Double-blinded 100 CABG, 
AVS, MVS 
Parikka et al. [56] Open 140 CABG 
Nystr6m et al. [26] Open 101 CABG 
Merrick et al. [14] Double-blinded 207 CABG, 
AVS, MVS 
Babin-Ebell et al. [15] Open 103 CABG 
Kowey et al. [19] Double-blinded 157 CABG 
Digitalis > No prophylaxis 
Digitalis < No prophylaxis 
Digitalis > No prophylaxis 
Propranolol > Placebo 
Propranolol > No prophylaxis 
Verapamil = Placebo 
Verapamil = No prophylaxis 
Verapamil = Placebo 
Acebutolol > No prophylaxis 
Sotalol > No prophylaxis 
Metoprolol > No prophylaxis 
Sotalol > Metoprolol 
Propranolol > No prophylaxis 
Digitalis = No prophylaxis 
Nadolol > Placebo 
Atenolol > No prophylaxis 
Sotalol > Placebo 
Amiodarone > Placebo 
Magnesium = Placebo 
Magnesium = Placebo 
Magnesium = Placebo 
Sotalol > Half dose of 
preoperative 
[3-blocker 
Propafenone = Atenolol 
Propranolol > No prophylaxis 
Diltiazem = No prophylaxis 
Digitalis + acebutolol = Digitalis + 
placebo 
a >; Proceeding A significantly more efficient in preventing postop- 
erative atrial tachyarrhythmia compared to proceeding B; =: no 
significant difference; <: proceeding A significantly less efficient 
in preventing postoperative atrial tachyarrhythmia compared to 
drug B (CABG coronary artery bypass grafting, AVS aortic valve 
surgery, MVS mitral valve surgery) 
postoperative atrial tachyarrhythmia was significantly 
reduced, although preoperative therapy with beta 
blockers was sometimes suspended in the control 
groups. This withdrawal may be a risk factor for postop- 
erative atrial tachyarrhythmia and may lead to a false 
high incidence in the placebo groups. 
A meta-analysis of 14 studies incorporating a total of 
2585 patients treated either with prophylactic beta 
blockers (n = 675), digitalis (n = 375), a combination of 
both (n = 139), or placebo (n = 1414) revealed the com- 
bination of beta blockers and digitalis to be significantly 
more effective than beta blockers alone, which in turn 
was significantly superior to placebo [53]. Digitalis 
alone had no significant effect and showed only a trend 
toward benefit. However, meta-analyses can never be 
used as final statements, asthe nonuniformity of the dif- 
ferent studies may make comparison difficult. Further- 
more, in a recent study, no significant additional effect 
of acebutolol could be demonstrated when given in con- 
junction with digitalis [19]. 
Amiodarone [54] and sotalol [2, 26, 44] have been 
compared to placebo in several open and double-blind- 
ed trials. In all studies, a significant reduction in postop- 
erative atrial tachyarrhythmia was observed. Again, in 
the placebo groups preoperative beta blockers or other 
cardiac medication were reduced or completely stop- 
ped, which may have led to a false high incidence of 
postoperative atrial tachyarrhythmias in these groups. 
In a study comparing sotalol with metoprolol, sotalol 
was significantly more effective [2]. 
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Table 2 Drug efficiency i  conversion of postoperative atrial tachyarrhythmia to sinus rhythm (only randomized and prospective stud- 
ies, 1982-1997) 
Authors Type of study Number of patients Type of operation Proceeding A Proceeding B 
and efficiency 
of conversion a 
Plumb et al. [68]  Double-blinded 28 CABG, AVS, CC Verapamil 
Hwang et al. [58] Double-blinded 14 CABG, ASD Verapamil 
Campbell et al. [66] Open 40 Not specified Sotalol 
Connolly et al. [21] Double-blinded 14 CABG, ASD, AVS Propafenone 
Gavaghan et al. [64] Open 56 Not specified Flecainide 
Wafa et al. [63] Open 29 CABG Flecainide 
McAlister et al. [42] Open, crossover 80 CABG, AVS, MVS Quinidine 
Hjelms et al. [61] Open 30 CABG, VSD, AVS Procainamide 
Ollitrault et al. [65] Double-blinded 86 CABG, AVS, MVS, CC Cibenzoline 
Cochrane et al. [10] Open 30 CABG, AVS, MVS Amiodarone 
Larbuisson et al. [62] Open 40 CABG, AVS Propafenone 
Frost et al. [67]  Double-blinded 98 CABG Dofetilide 
= Placebo 
= Placebo 
= Digitalis + 
disopyramide 
> Placebo 
= Digitalis + 
disopyramide 
> Digitalis 
> Amiodarone 
> Digitalis 
> Placebo 
= Digitalis 
= Amiodarone 
= Placebo 
a >: Proceeding A significantly more efficient in converting postop- 
erative atrial tachyarrhythmias to sinus rhythm as compared to 
drug B: =: no significant difference (ASD atrial septal defect, AVS
aortic valve surgery, MVS mitral valve surgery, VSD ventricular 
septal defect, CABG coronary artery bypass graft, CC correction 
of congenital heart disease) 
Diltiazem [15] and verapamil [24, 27, 55] have been 
compared to placebo in open and ouble-blinded stud- 
ies. No prophylactic effect for postoperative atrial tach- 
yarrhythmia of either drug could be demonstrated. Pati- 
ents given diltiazem experienced exactly the same inci- 
dence of supraventricular tachyarrhythmias as those in 
the placebo group. In addition, the diltiazem group 
needed significantly more inotropic support. In only 
one [55] of the three trials comparing verapamil to pla- 
cebo was ventricular heart rate significantly lowered 
during atrial tachyarrhythmia. Moreover, a significant 
incidence of severe side effects, including hypotension 
and pulmonary edema, was observed [55]. 
Magnesium has been investigated in several trials. In 
a controlled study, a significantly higher incidence of 
atrial tachyarrhythmia w s observed in hypomagnese- 
mic compared to normomagnesemic patients [9]. How- 
eve1; prophylactic magnesium supplementation was in- 
effective. In accordance with this finding, hypomagnese- 
mic patients experienced significantly more episodes of 
atrial fibrillation, but prophylactic magnesium did not 
significantly lower the number of patients experiencing 
atrial fibrillation [8]. Indeed, a nonsignificant increase 
in atrial fibrillation has been reported with prophylactic 
magnesium [56]. However, patients in this group were 
significantly older and more frequently had a history of 
atrial fibrillation compared with those receiving place- 
bo. 
The prophylactic use of postoperative digitalis is con- 
troversial. Some studies identified a positive effect [23, 
57]. By contrast, others [48] found a significant increase 
in postoperative atrial tachyarrhythmias with prophy- 
lactic digitalization. In a meta-analysis, only a trend to- 
ward a benefit was demonstrated [53]. 
Triiodothyronine, given for 9 h following unclamping 
of the aorta, was compared to placebo in a double-blind- 
ed manner in 131 patients with an ejection fraction of 
< 40% following coronary artery bypass grafting [18], 
and this led to a significant decrease in atrial fibrillation 
after 25-120 h. However, possible mechanisms of action 
remain speculative. 
Therapy of postoperative atrial tachyarrhythmias 
The therapeutic goals of correcting atrial tachyarrhyth- 
mia are rapid reduction of the ventricular rate and early 
conversion to sinus rhythm [10]. In cases of hemody- 
namic instability, acute myocardial ischemia, or hyper- 
trophic cardiomyopathy, for example, associated with 
severe aortic stenosis, DC cardioversion is the therapy 
of choice [58]. 
Even patients with chronic preoperative atrial fibril- 
lation can be converted to sinus rhythm [59, 60], a suc- 
cessful conversion occuring in 60-77 % of patients treat- 
ed pharmacologically, with or without DC cardiover- 
sion. In all of these patients, atrial fibrillation was pre- 
sent for 48 to 72 months. A left atrial diameter less 
than 45-52 mm, good functional capacity and shorter 
duration of preoperative atrial fibrillation were predic- 
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tors of successful cardioversion; 70 % remained in sinus 
rhythm over a mean follow-up period of 17 months 
[60]. Table 2 summarizes the results of randomized and 
prospective trials evaluating drug efficiency in convert- 
ing postoperative atrial tachyarrhythmia to sinus 
rhythm. 
Drugs and efficiency 
Procainamide 
In a small trial of 30 patients, procainamide (25 mg/min 
up to 15 mg/kg intravenously) was compared to digitalis 
(0.75-1.0 mg i.v.) [61]. In the procainamide group signif- 
icantly more patients (87 vs 60%) converted to sinus 
rhythm and conversion occurred significantly faster (40 
vs 540 min). No serious complication was observed in 
the procainamide group. 
Propafenone 
Propafenone (2mg/kg i. v. over 10 min) was compared to 
placebo in a small double-blinded crossover study: 43 % 
of patients converted within 10 rain of receiving propafe- 
none, but none after placebo [21]. In addition, the ven- 
tricular rate decreased significantly in the propafenone 
group, the only side effect being a decrease in systolic 
blood pressure of 9 mmHg. Propafenone (1-2 mg/kg 
over 10 rain followed by an infusion of 420 mg in 24 h) 
was compared to amiodarone (2.5-5 mg/kg over 10 min 
followed by an infusion of 900 mg in 24 h) in 40 patients 
following coronary artery bypass grafting or aortic valve 
replacement [62]. No beta blocking agents, calcium 
channel blockers, or other antiarrhythmics were given 
concurrently. There was no significant difference be- 
tween the two groups in terms of conversion rates or 
hemodynamic performance. Propafenone seemed to act 
slightly faster than amiodarone. 
Flecainide 
By comparison with digitalis (0.5 mg i.v. followed by 
0.25 mg after 6 and 12 h) [63] flecainide (1 mg/kg over 
10 min followed by an infusion of 1.5 mg/kg per h for 
i h, then 0.25 mg/kg per h for 24 h) led to conversion to 
sinus rhythm significantly more often. No patient in the 
digitalis group converted to sinus rhythm. No serious 
side effects were observed in either group. Flecainide 
(2 mg/kg i.v. over 20 min followed by an infusion of 
0.2 mg/kg per h for 12 h) compared to a combination of 
digitalis (0.75 mg i.v.) followed by disopyramide 2 h lat- 
er (2 mg/kg and an infusion of 0.4 mg/kg per h for 10 h) 
showed almost identical conversion rates, but flecainide 
acted significantly faster (80 vs 220 min) [64]. Consider- 
ing the prolonged time for conversion using digitalis, 
this group of patients may have experienced sponta- 
neous conversion. One fatality in the flecainide group 
was due to intractable ventricular fibrillation. 
Cibenzoline 
Cibenzoline (1.2 mg/kg over 2 min i.v.) has been com- 
pared to placebo in a double-blinded trial, in which no 
other antiarrhythmics were given concurrently [65]. Sig- 
nificantly more patients of the active group converted to 
sinus rhythm (30 vs 6.9 %), and the ventricular rate was 
significantly lower. No side effects were noted in this 
study population, which had an average jection frac- 
tion of approximately 60%. 
Beta blockers 
No prospective randomized studies comparing the ther- 
apeutic use of beta blockers with other drugs or placebo 
have been performed. 
Amiodarone 
Amiodarone (5 mg/kg up to 400 mg over 30 min, then 
25 mg/h and a possible rise to 40 mg/h) has been com- 
pared to digitalis (1 mg over 9 h i.v. followed by oral 
maintenance) [10] and showed comparable conversion 
rates to sinus rhythm within 24 h. The ventricular rate 
during atrial fibrillation, blood pressure, and side effects 
were also comparable. Amiodarone (5mg/kg over 
20 min i.v.) was compared to Quinidine (2 x 400 mg 
per os in 4 h) in a randomized crossover study [42]. Sig- 
nificantly more patients converted under quinidine as 
with the first drug (64 vs 41%), the difference being no 
more significant after the second. Side effects were ob- 
served in significantly more patients receiving quinidine 
first, some of which were severe (e.g., torsades de 
pointes, severe nausea and vomiting). 
Sotalol 
Sotalol (1 mg/kg bolus, plus 0.2 mg/kg over 12 h) has 
been compared to a combination of digitalis plus dis- 
opyramide (digitalis 0.75 mg i.v. followed 2 h later by 
disopyramide 2 mg/kg bolus and 0.4 mg/kg per h for 
10 h) [66]. Conversion rates were equal in both groups, 
but those in the sotalol group converted significantly 
faster (58 vs 187 rain) and had fewer relapses. The most 
frequent side effect attributable to sotalol was hypoten- 
sion, leading to a drop in blood pressure of at least 
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20 mmHg, or to below 90 mmHg in over 75 % of pati- 
ents. Disopyramide had to be stopped in several cases 
due to anticholinergic side effects. 
Dqfetilide 
Dofetilide, aclass III antiarrhythmic agent without neg- 
ative inotropic effects, has been compared in a double- 
blinded manner in two dosages (4 ~tg/kg and 8 vg/kg 
over 15 min) to placebo [67]. Within 3 h of drug admin- 
istration, conversion rates were 24 and 44 % for placebo 
and 8 btg/kg dofetilide respectively, a nonsignificant dif- 
ference. Dofetilide was well tolerated and had no nega- 
tive inotropic effect. 
Verapamil 
Verapamil (0.075 mg/kg followed by 0.15 mg/kg later) 
has been compared to placebo in two double-blinded 
crossover studies [58, 68]. The ventricular heart rate 
during atrial fibrillation was significantly reduced, al- 
though the effect wore off rapidly after discontinuing 
the drug. Verapamil was not superior to placebo in con- 
version into sinus rhythm, but led to a significant reduc- 
tion in diastolic blood pressure [58]. 
Digitalis 
Digitalis has long been considered the drug of choice for 
supraventricular arrhythmia [10], although it has no in- 
trinsic antiarrhythmic effect [69]. No prospective ran- 
domized studies have been done comparing digitalis to 
placebo. Digitalis alone or in combination with disopy- 
ramide was compared to procainamide, flecainide, ci- 
benzoline, amiodarone, and sotalol, as summarized in
Table 2, but in no case was digitalis better than the com- 
parative drug. In addition, in the nonoperative setting 
digitalis does not convert atrial fibrillation faster or bet- 
ter than placebo [70]. It may have an indirect beneficial 
effect mediated via improvement of hemodynamic sta- 
tus [69] and lowering of heart rate. 
Anticoagulation 
Left atrial thrombus began to form in 14 % of 143 pati- 
ents with acute atrial fibrillation within 3 days, as detect- 
ed by transesophageal echocardiography (TEE) [71]. 
However, among patients presenting with atrial fibrilla- 
tion that was clinically estimated to have lasted less 
than 48 h, the likelihood of cardioversion - related clini- 
cal thromboembolism was very low [72]. The use of 
TEE to identify atrial thrombus and decide on its sever- 
ity is controversial [73, 74]. A meta-analysis of three 
randomized trials has suggested a small positive effect 
of aspirin in preventing stroke [75]. Anticoagulation 
with warfarin is more effective and significantly reduces 
the incidence of embolism [76-78]. But all studies men- 
tioned have been performed in a nonpostoperative set- 
ting. Therefore, no therapeutic guidelines exist for pati- 
ents after cardiac surgery. The risk of thromboembolism 
must be weighed against he possible hazard of antico- 
agulation, especially when administered shortly after 
major surgery. A reasonable approach at present is that 
if atrial fibrillation persists for 24 h or more, anticoagu- 
lation should be started. 
A practical approach 
As in the management of any other medical problem, all 
patients have to be evaluated on an individual basis, 
considering factors such as type of operation, age, pre- 
operative medication, and hemodynamic status. 
Prophylaxis 
Older patients, with a history of atrial fibrillation under- 
going heart valve operations are at an increased risk and 
benefit from pharmacological prophylaxis. As the peak 
incidence of atrial tachyarrhythmia is during the second 
to third postoperative day, prophylaxis should be started 
as early as possible. Beta blockers are the most widely in- 
vestigated rugs for the prophylaxis of postoperative 
atrial tachyarrhythmias and are considered by many to 
be the drug of choice. In established preoperative beta 
blockade, they should be continued uring the whole 
postoperative period. Combined therapy with digitalis 
may be considered inpatients with depressed left ventric- 
ular function. Sotalol has been used with good results and 
may even be superior to other beta blockers. In the case 
of intolerance tobeta blockers, amiodarone and propafe- 
none has been shown to be effective. Presently none of 
the data justify the prophylactic use of digitalis alone, 
nor calcium antagonists. In recurrent atrial tachyarrhyth- 
mia, amiodarone or sotalol may be used as prophylaxis, 
even if controlled studies are lacking. No data exist con- 
cerning the duration of prophylactic medication. 
Therapy 
In patients with hemodynamically poorly tolerated atri- 
al tachyarrhythmia, DC cardioversion is imperative. In 
the case of hemodynamic stability, the goal of therapy 
is to control ventricular rate and convert to sinus 
rhythm. If ventricular function is normal, rate control 
may be achieved using careful titration of beta blockers. 
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Digitalis may be considered in patients with congestive 
heart failure. 
If conversion to sinus rhythm does not occur sponta- 
neously, procainamide, propafenone,  or flecainide is ef- 
fective and safe for pharmacologic ardioversion. No 
control led studies indicate that the use of beta blockers 
or calcium antagonists is justified in cardioversion. Al- 
though used by many, no convincing data exist either 
for the use of amiodarone or digitalis. We do not recom- 
mend prolonged use of flecainide due to its possible 
proarrhythmic effect. If atrial fibrillation is recurrent or 
lasts more than 24 h, intravenous anticoagulation with 
heparin, fol lowed by oral anticoagulation, is recom- 
mended. Two to four weeks of anticoagulation is pru- 
dent before elective DC cardioversion. 
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Note added in proof 
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